Skip to main content
SpringerLink
Log in

Isolation, cloning and characterisation of IP-receptors

  • Chapter
Prostacyclin and Its Receptors

  • 68 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kiriyama M, Ushikubi F, Kobayashi T et al. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 1997;122:217–224.

    Article  PubMed  CAS  Google Scholar 

  2. Hébert RL, Regnier L, Peterson LN. Rabbit cortical collecting ducts express a novel prostacyclin receptor. Am J Physiol 1995;268:F145–F154.

    PubMed  Google Scholar 

  3. Takechi H, Matsumura K, Watanabe Y et al. A novel subtype of the prostacyclin receptor expressed in the central nervous system. J Biol Chem 1996;271:5901–5906.

    PubMed  CAS  Google Scholar 

  4. Ishikawa T, Tamai Y, Rochelle JM et al. Mapping of the genes encoding mouse prostaglandin D, E, and F and prostacyclin receptors. Genomics 1996;32:285–288.

    Article  PubMed  CAS  Google Scholar 

  5. Toh H, Ichikawa A, Narumiya S. Molecular evolution of receptors for eicosanoids. FEBS Lett 1995;361:17–21.

    Article  PubMed  CAS  Google Scholar 

  6. Kedzie KM, Donello JE, Krauss HA et al. A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs. Mol Pharmacol 1998;54:584-590.

    Google Scholar 

  7. Murata T, Ushikubi F, Matsuoka T et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 1997;388:678–682.

    PubMed  CAS  Google Scholar 

  8. Leigh PJ, Cramp WA, MacDermot J. Identification of the prostacyclin receptor by radiation inactivation. J Biol Chem 1984;259: 12431–12436.

    PubMed  CAS  Google Scholar 

  9. Tsai A, Hsu M-J, Vijjeswarapu H et al. Solubilization of prostacyclin membrane receptors from human platelets. J Biol Chem 1989;264:61–67.

    PubMed  CAS  Google Scholar 

  10. Ito S, Hashimoto H, Negishi M et al. Identification of the prostacyclin receptor by use of [15-3H1]19-(3-azidophenyl)-20-norisocarbacyclin, an irreversible specific photoaffinity label. J Biol Chem 1992;267:20326–20330.

    PubMed  CAS  Google Scholar 

  11. Boie Y, Rushmore TH, Darmon-Goodwin A et al. Cloning and expression of a cDNA for the human prostanoid IP receptor. J Biol Chem 1994;269:12173–12178.

    PubMed  CAS  Google Scholar 

  12. Katsuyama M, Sugimoto Y, Namba T et al. Cloning and expression of a cDNA for the human prostacyclin receptor. FEBS Lett 1994;344:74–78.

    Article  PubMed  CAS  Google Scholar 

  13. Nakagawa 0, Tanaka I, Usui T et al. Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system. Circulation 1994;90: 1643–1647.

    PubMed  CAS  Google Scholar 

  14. Namba T, Oida H, Sugimoto Y et al. cDNA cloning of a mouse prostacyclin receptor. J Biol Chem 1994;269:9986–9992.

    PubMed  CAS  Google Scholar 

  15. Sasaki Y, Usui T, Tanaka I et al. Cloning and expression of a cDNA for rat prostacyclin receptor. Biochim Biophys Acta 1994; 1224:601–605.

    PubMed  Google Scholar 

  16. Smyth EM, Nestor PV, Fitzgerald GA. Agonist-dependent phosphorylation of an epitope-tagged human prostacyclin receptor. J Biol Chem 1996;271:33698–33704.

    Article  PubMed  CAS  Google Scholar 

  17. Pierce KL, Gil DW, Woodward DF et al. Cloning of the human prostanoid receptors, Trends Pharmacol Sci 1995;16:253–256.

    Article  PubMed  CAS  Google Scholar 

  18. Negishi M, Sugimoto Y, Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim Biophys Acta 1995;1259: 109–120.

    PubMed  Google Scholar 

  19. Ushikubi F, Hirata M, Narumiya S. Molecular biology of prostanoid receptors; an overview. J Lipid Mediators Cell Signal 1995; 12:343–359.

    CAS  Google Scholar 

  20. Chan CL, Lau HYA. Effects of prostanoids on immunologically activated rat mast cells. XXVI Annual Meeting of the European Histamine Research Society 1997;p59.

    Google Scholar 

  21. Hasse A, Bönisch D, Schrör K. Gene structure and expression of a prostacyclin receptor in vascular smooth muscle cells. Naunyn-Schmied Arch Pharmacol 1997;355:Rl9.

    Google Scholar 

  22. Hirata M, Ushikubi F, Narumiya S. Prostaglandin I receptor and prostaglandin D receptor. J Lipid Mediators Cell Signal 1995;12:393–404.

    CAS  Google Scholar 

  23. Narumiya S, Hirata N, Namba T et al. Structure and function of prostanoid receptors. J Lipid Mediators 1993;6: 155–161.

    CAS  Google Scholar 

  24. Kelly E, Keen M, Nobbs P et al. Segregation of discrete Gsα-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids. Br J Pharmacol 1990;99:309–316.

    PubMed  CAS  Google Scholar 

  25. Leigh PJ, MacDermot J. Desensitization of prostacyclin responsiveness in a neuronal hybrid cell line: selective loss of high affinity receptors. Br J Pharmacol 1985;85:237–247.

    PubMed  CAS  Google Scholar 

  26. Schillinger E, Prior G. Prostaglandin I2 receptors in a particulate fraction of platelets of various species. Biochem Pharmacol 1980;29:2297–2299.

    Article  PubMed  CAS  Google Scholar 

  27. Rücker W, Schrör K. Evidence for high affinity prostacyclin binding sites in vascular tissue: radioligand studies with a chemically stable analogue. Biochem Pharmacol 1983;321:2405–2410.

    Google Scholar 

  28. Lombroso M, Nicosia S, Paoletti R et al. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes. Prostaglandins 1984;27:321–333.

    Article  PubMed  CAS  Google Scholar 

  29. MacDermot J, Barnes PJ. Activation of guinea pig pulmonary adenylate cyclase by prostacyclin. Eur J Pharmacol 1980;67:417–425.

    Article  Google Scholar 

  30. MacDermot J, Barnes PJ, Waddell KA et al. Prostacyclin binding to guinea pig pulmonary receptors. Eur J Pharmacol 1981;75:127–130.

    Article  PubMed  CAS  Google Scholar 

  31. Lerner RW, Lopaschuk GD, Catena RC et al.[3H] Iloprost andprostaglandin E2 compete for the same receptor site on cardiac sarcolemmal membranes. Biochim Biophys Acta 1992;1105:189–192.

    PubMed  CAS  Google Scholar 

  32. Schmid A, Thierauch K-H, Schleuning W-D et al. Splice variants of the human EP3 receptor for prostaglandin E2. Eur J Biochem 1995;228:23–30.

    Article  PubMed  CAS  Google Scholar 

  33. Kotani M, Tanaka I, Ogawa Y et al. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. Mol Pharmacol 1995;48:869–879.

    PubMed  CAS  Google Scholar 

  34. Sugimoto Y, Namba T, Honda A et al. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J Biol Chem 1992;267:6463–6466.

    PubMed  CAS  Google Scholar 

  35. Breyer RM, Emeson RB, Tarng J-L et al. Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor. J Biol Chem 1994;269:6163–6169.

    PubMed  CAS  Google Scholar 

  36. Hall JM, Strange PG. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells. Biosci Reports 1984;4:941–948.

    CAS  Google Scholar 

  37. Watanabe T, Yatomi Y, Sunago S et al. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s. Blood 1991;78:2328–2336.

    PubMed  CAS  Google Scholar 

  38. Jones RL, Qian Y, Wise H et al. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery. J Cardiovasc Pharmacol 1997;29:525–535.

    Article  PubMed  CAS  Google Scholar 

  39. Buritova J, Honoré P, Besson JM. Ketoprofen produces profound inhibition of spinal c-Fos protein expression resulting from an inflammatory stimulus but not from noxious heat. Pain 1996;67:379–389.

    Article  PubMed  CAS  Google Scholar 

  40. Merritt JE, Hallam TJ, Brown AM et al. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. Br J Pharmacol 1991;102:251–259.

    PubMed  CAS  Google Scholar 

  41. Siegl AM, Smith JB, Silver MJ et al. Selective binding site for [3H] prostacyclin on platelets. J Clin Invest 1979;63:215–220.

    Article  PubMed  CAS  Google Scholar 

  42. Virgolini I, Li S, Sillaber C et al. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. J Biol Chem 1992;267:12700–12708.

    PubMed  CAS  Google Scholar 

  43. Watanabe Y, Suzuki M, Björkman M et al. Brain uptake of 11C-labelled stable prostacyclin receptor ligand studied by positron emission tomography. Neuroimage 1997;5:A1.

    Google Scholar 

  44. Kobayashi T, Kiriyama M, Hirata T et al. Identification of domains conferring ligand binding specificity to the prostanoid receptor. J Biol Chem 1997;272:15154–15160.

    PubMed  CAS  Google Scholar 

  45. Blair IA, MacDermot J. The binding of [3H]-prostacyclin to membranes of a neuronal somatic hybrid. Br J Pharmacol 1981;72:435–441.

    PubMed  CAS  Google Scholar 

  46. Blair IA, Leigh PJ, MacDermot J. Desensitization of prostacyclin receptors in a neuronal hybrid cell line. Br J Pharmacol 1982;77:121–127.

    PubMed  CAS  Google Scholar 

  47. Barr DB, Duncan JA, Kiernan JA et al. Binding and biological actions of prostaglandin E2 and I2 in cells isolated from rabbit gastric mucosa. J Physiol 1988;405:39–55.

    PubMed  CAS  Google Scholar 

  48. Town M-H, Schillinger E, Speckenbach A et al. Identification and characterisation of a prostacyclin-like receptor in bovine coronary arteries using a specific and stable prostacyclin analogue, ciloprost, as radioactive ligand. Prostaglandins 1982;24:61–72.

    Article  PubMed  CAS  Google Scholar 

  49. Sawai T, Negishi M, Nishigaki N et al. Enhancement by protein kinase C of prostacyclin receptor-mediated activation of adenylate cyclase through a calmodulin/myristoylated alanine-rich C kinasesubstrate (MARCKS)system in IC2 mast cells. J Biol Chem 1993;268:1995–2000.

    PubMed  CAS  Google Scholar 

  50. Eggerman TL, Andersen NH, Robertson RP. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets. J Pharmacol Exp Ther 1986;236:568–573.

    PubMed  CAS  Google Scholar 

  51. Kahn NN, Bauman WA, Sinha AK. Demonstration of a novel circulating anti-prostacyclin receptor antibody. Proc Natl Acad Sci USA 1997;94:8779–8782.

    Article  PubMed  CAS  Google Scholar 

  52. Blair IA, Hensby CN, MacDermot J. Prostacyclin-dependent activation of adenylate cyclase in a neuronal somatic hybrid: prostanoid structure-activity relationships. Br J Pharmacol 1980;69:519–525.

    PubMed  CAS  Google Scholar 

  53. Oka M, Negishi M, Yamamoto T et al. Prostacyclin (PGI) receptor binding and cyclic AMP synthesis activities ofPGI1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cells. Biol Pharm Bull 1994;17:74–77.

    PubMed  CAS  Google Scholar 

  54. Hiroi T, Maruyama K, Hattori K et al. Affinity for [3H]iloprost bindingsites and CAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells. Jpn J Pharmacol 1997;74:37–43.

    PubMed  CAS  Google Scholar 

  55. Tanaka M, Kojima C, Muramatsu M et al. Binding affinities of isocarbacyclin methyl ester and its free acid to prostanoid receptors. Arzneim-Forsch 1995;45:967–970.

    CAS  Google Scholar 

  56. Armstrong RA, Lawrence RA, Jones RL et al. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors. Br J Pharmacol 1989;97:657–668.

    PubMed  CAS  Google Scholar 

  57. Seiler S, Brassard CL, Arnold AJ et al. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation. J Pharmacol Exp Ther 1990;255:1021–1026.

    PubMed  CAS  Google Scholar 

  58. Seiler SM, Brassard CL, Federici ME et al. 2-[3-[2-(4,5-Diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: (1) inhibition of platelet aggregation and mechanism of action. Thromb Res 1994;74:115–123.

    PubMed  CAS  Google Scholar 

  59. Meanwell NA, Romine JL, Rosenfeld MJ et al. Non-prostanoid prostacyclin mimetics. 5. Structure-activity-relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid. J Med Chem 1993;36:3884–3903.

    PubMed  CAS  Google Scholar 

  60. Seiler SM, Brassard CL, Federici ME et al. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding. Prostaglandins 1997;53:21–35.

    Article  PubMed  CAS  Google Scholar 

  61. Huang C, Tai H-H. Expression and site-directed mutagenesis of mouse prostaglandin E2 receptor EP3 subtype in insect cells. Biochem J 1995;307:493–498.

    PubMed  CAS  Google Scholar 

  62. Negishi M, Harazono A, Sugimoto Y et al. Selective coupling of prostaglandin E receptor EP3D to multiple G proteins depending on interaction of the carboxylic acid of agonist and arginine residue of seventh transmembrane domain. Biochem Biophys Res Commun 1995;212:279–285.

    Article  PubMed  CAS  Google Scholar 

  63. Negishi M, Irie A, Sugimoto Y et al. Selective coupling of prostaglandin E receptor EP3D to Gi and Gs through interaction of-α-carboxylic acidof agonist and arginine residue of seventh transmembrane domain. J Biol Chem 1995;270:16122–16127.

    PubMed  CAS  Google Scholar 

  64. Smith JAM, Amagasu SM, Eglen RM et al. Characterization of prostanoid receptorevoked responses in rat sensory neurones. Br J Pharmacol 1998;124:513–523.

    PubMed  CAS  Google Scholar 

  65. Oka M, Negishi M, Nishigaki N et al. Two types of prostacyclin receptor coupling to stimulation of adenylate cyclase and phophatidylinositol hydrolysis in a cultured mast cell line, BNu-2c13 cells. Cell Signal 1993;5:643–650.

    Article  PubMed  CAS  Google Scholar 

  66. Vassaux G, Gaillard D, Aihaud G et al. Prostacyclin is a specific effector of adipose cell differentiation. J Biol Chem 1992;267:11092–11097.

    PubMed  CAS  Google Scholar 

  67. Turner JT, Camden JM, Kansra S et al. Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL. J Pharmacol Exp Ther 1992;263:708–716.

    PubMed  CAS  Google Scholar 

  68. Schwaner I, Seifert R, Schultz G. Receptor-mediated increases in cytosolic Ca+2 in the human erythroleukaemia cell line involve pertussis toxin-sensitive and-insensitive pathways. Biochem J 1992;281:301–307.

    PubMed  CAS  Google Scholar 

  69. Schwaner I, Seifert R, Schultz G. The prostacyclin analogues, cicaprost and iloprost, increase cytosolic Ca2+ concentration in the human erythroleukemia cell line, HEL, via pertussis toxin-insensitive G-proteins. Eicosanoids 1992;5:S10–S12.

    PubMed  Google Scholar 

  70. Adachi M, Ryo R, Yoshida A et al. Elevation of intracellular calcium ion by prostaglandin E1 and its inhibition by protein kinase C in a human megakaryocyte leukemia cell line. Cancer Res 1989;49:3805–3808.

    PubMed  CAS  Google Scholar 

  71. Feoktistov I, Breyer RM, Biaggioni I. Prostanoid receptor with a novel pharmacological profile in human erythroleukemia cells. Biochem Pharmacol 1997;54:917–926.

    Article  PubMed  CAS  Google Scholar 

  72. Vassaux G, Gaillard D, Darimont C et al. Differential response of preadipocytes and adipocytes to prostacyclin and prostaglandin E2: Physiological implications. Endocrinology 1992;131:2393–2398.

    CAS  Google Scholar 

  73. Vassaux G, Gaillard D, Aihaud G et al. Prostacyclin is a specific effector of adipose cell differentiation. J Biol Chem 1992;267:11092–11097.

    PubMed  CAS  Google Scholar 

  74. Aubert J, Ailhaud G, Negrel R. Evidence for a novel regulatory pathway activated by (carba)prostacyclin in preadipose and adipose cells. FEBS Lett 1996;397:117–121.

    Article  PubMed  CAS  Google Scholar 

  75. Cazevieille C, Muller A, Meynier F et al. Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem Int 1994;24:395–398.

    Article  PubMed  CAS  Google Scholar 

  76. Cazevieille C, Muller A, Bonne C. Prostacyclin (PGI2) protects rat cortical neurons in culture against hypoxia/reoxygenation and glutamate-induced injury. Neurosci Lett 1993;160:106–108.

    Article  PubMed  CAS  Google Scholar 

  77. Kenakin T. The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 1996;48:413–463.

    PubMed  CAS  Google Scholar 

  78. Premont RT, Inglesse J, Lefkowitz RJ. Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J 1995;9:175–182.

    PubMed  CAS  Google Scholar 

  79. Smyth EM, Hong Li W, Fitzgerald GA. Phosphorylation of the prostacyclin receptor during homologous desensitization. J Biol Chem 1998;273:23358–23266.

    Article  Google Scholar 

  80. Murray R, Shipp E, Fitzgerald GA. Prostaglandin endoperoxide/thromboxane A2 receptor desensitization. J Biol Chem 1990;265:21670–21675.

    PubMed  CAS  Google Scholar 

  81. Watanabe T, Sunaga S, Togo M et al. Protein kinase C plays a key role in the cross-talk between intracellular signalings via prostanoid receptors in a megakaryoblastic cell line, MEG-01s. Biochim Biophys Acta 1996;1304:161–169.

    PubMed  Google Scholar 

  82. Neuschaferrube F, Hanecke K, Blaschke V et al. The C-terminal domain of the Gs-coupled EP4 receptor confers agonist-dependent coupling control to Gi but no coupling to Gs in a receptor hybrid with the Gi-coupled EP3 receptor. FEBS Lett 1997;401:185–190.

    CAS  Google Scholar 

  83. Audoly L, Breyer RM. Substitution of charged amino acid residues in transmembrane regions 6 and 7 affect ligand binding and signal transduction of the prostaglandin EP3 receptor. Mol Pharmacol 1997;51:61–68.

    PubMed  CAS  Google Scholar 

  84. Corsini A, Folco GC, Fumagalli R et al. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets. Br J Pharmacol 1987;90:255–261.

    PubMed  CAS  Google Scholar 

  85. Ragazzi E, Chinellato A, Lille Ü et al. Pharmacological properties of MM-706, a new prostacyclin derivative. Gen Pharmacol 1995;26:703–709.

    PubMed  CAS  Google Scholar 

  86. Jones RL, Qian YM, Wong HNC et al. Prostanoid action on the human pulmonary vascular system, Clin Exp Pharmacol Physiol 1997;24:I969–972.

    Google Scholar 

  87. Fassina G, Froldi G, Caparrotta L. A stable isosterically modified prostacyclin analogue, FCE-22176, acting as a competitive antagonist to prostacyclin in guinea-pig trachea and atria. Eur J Pharmacol 1985;113:459–460.

    Article  PubMed  CAS  Google Scholar 

  88. Caparrotta L, Ceserani R, Mongelli N et al. Depression and excitation induced in mice by two geometric isomers of (+)13,14-didehydro-20-methyl-carboprostacyclin, FCE 22177 and FCE 22176. Comparison with effects on blood pressure and platelet aggregation. Prostaglandins 1987;33:351–362.

    Article  PubMed  CAS  Google Scholar 

  89. Wilkins AJ, MacDermot J. The putative prostacyclin receptor antagonist (FCE-22176) is a full agonist on human platelets and NCB-20 cells. Eur J Pharmacol 1986;127:117–119.

    Article  PubMed  CAS  Google Scholar 

  90. Dong YJ, Jones RL, Wilson NH. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues. Br J Pharmacol 1986;87:97–107.

    PubMed  CAS  Google Scholar 

  91. Lawrence RA, Jones RL, Wilson NH. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum. Br J Pharmacol 1992;105:271–278.

    PubMed  CAS  Google Scholar 

  92. Meanwell NA, Romine JL, Seiler SM. Non-prostanoid prostacyclin mimetics. Drugs Future 1994;19:361–385.

    Google Scholar 

  93. Merritt JE, Brown AM, Bund S et al. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor. Br J Pharmacol 1991;102:260–266.

    PubMed  CAS  Google Scholar 

  94. Armstrong RA, Jones RL, MacDermot J et al. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics. Br J Pharmacol 1986;87:543–551.

    PubMed  CAS  Google Scholar 

  95. Wise H. The inhibitory effects of non-prostanoid prostacyclin mimetics on rat neutrophil function. Prostaglandins Leukot Essent Fatty Acids 1996;54:351–360.

    PubMed  CAS  Google Scholar 

  96. Wise H, Chow BS. Effect of non-prostanoid prostacyclin mimetics on cyclic AMP production by neuronal SK-N-SH cells. Prostaglandins Leukot Essent Fatty Acids 1996;S:S1 p35.

    Google Scholar 

  97. Wise H, Qian Y, Jones RL. A study of prostacyclin mimetics distinguishes neuronal from neutrophil IP receptors. Eur J Pharmacol 1995;278:265–269.

    Article  PubMed  CAS  Google Scholar 

  98. Krane A, MacDermot J, Keen M. Desensitization of adenylate cyclase responses following exposure to IP prostanoid receptor agonists. Biochem Pharmacol 1994;47:953–959.

    Article  PubMed  CAS  Google Scholar 

  99. Giovanazzi S, Accomazzo MR, Letari O et al. Internalization and down-regulation of the prostacyclin receptor in human platelets. Biochem J 1997;325:71–77.

    PubMed  CAS  Google Scholar 

  100. Edwards RJ, MacDermot J, Wilkins AJ. Prostacyclin analogues reduce ADP-ribosylation of the α-subunit of the regulatory Gs-protein and diminish adenosine (A2) responsiveness of platelets. Br J Pharmacol 1987;90:501–510.

    PubMed  CAS  Google Scholar 

  101. Jaschonek K, Faul C, Schmidt H et al. Desensitization of platelets with iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase. Eur J Pharmacol 1988;147:187–196.

    Article  PubMed  CAS  Google Scholar 

  102. Williams RJ, Kelly E. Gsα-dependent and-independent desensitisation of prostanoid-activated adenylyl cyclase in NG108-15 cells. Eur J Pharmacol 1994;268:177–186.

    PubMed  CAS  Google Scholar 

  103. Krane A, Keen M. The effect of iloprost pretreatment on the sub-cellular localization of IP prostanoid receptors and Gsα in NG108-15 cells. Br J Pharmacol 1995;115:137P.

    Google Scholar 

  104. Krane A, Keen M. The effect of inhibitors of internalization on IP prostanoid receptor down-regulation in NG108-15 cells. Br J Pharmacol 1995;115:138P.

    Google Scholar 

  105. Keen M, Krane A. The effect of K+-depletedmediumoniloprost-andforskolin-mediated down-regulation of IP prostanoid receptors in NG108-15 cells. Br J Pharmacol 1996;117:72P.

    Google Scholar 

  106. Pearce D, Keen M. The effect of cycloheximide on IP prostanoid receptor down-regulation in NG108-15 cells. Br J Pharmacol 1995;116:19P.

    Google Scholar 

  107. Ashby B. Interactions among prostaglandin receptors. Receptor 1994;4:31–42.

    PubMed  CAS  Google Scholar 

  108. Zucker T-P, Böznisch D, Hasse A et al. Tolerance development to antimitogenic actions of prostacyclin but not of prostaglandin E1 in coronary artery smooth muscle cells. Eur J Pharmacol 1998;345:213–220.

    Article  PubMed  CAS  Google Scholar 

  109. Bastepe M, Ashby B. The long cytoplasmic carboxyl terminus of the prostaglandin E2 receptor EP4 subtype is essential for agonist-induced desensitization. Mol Pharmacol 1997;51:343–349.

    PubMed  CAS  Google Scholar 

  110. Nakagawa O, Sasaki Y, Tanaka I et al. Gene expression of prostacyclin receptor in the hypertrophied heart of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1995;(Suppl 1):S270–S272.

    Google Scholar 

  111. Nakao K, Lesener B, Nakao K et al. Localization of the prostacyclin receptor in human kidney. Kidney International 1999;54:1899–1908.

    Google Scholar 

  112. Sasaki Y, Takahashi T, Tanaka I et al. Expression of prostacyclin receptor in human megakaryocytes. Blood 1997;90:1039–1046.

    PubMed  CAS  Google Scholar 

  113. Oida H, Namba T, Sugimoto Y et al. In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br J Pharmacol 1995;116:2828–2837.

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

(2002). Isolation, cloning and characterisation of IP-receptors. In: Prostacyclin and Its Receptors. Springer, Boston, MA. https://doi.org/10.1007/0-306-46822-0_4

Download citation

  • DOI: https://doi.org/10.1007/0-306-46822-0_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46308-2

  • Online ISBN: 978-0-306-46822-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation